Clinical and morphological aspects of neoadjuvant chemotherapy efficacy in patients with aggressive luminal HER2-negative breast cancer

• Autores principales: D. A. Morozov (Autor), I. V. Kolyadina (Autor), I. V. Poddubnaya (Autor), I. P. Ganshina (Autor), S. V. Khokhlova (Autor), V. V. Kometova (Autor), V. V. Rodionov (Autor)
• Formato: Libro
• Publicado: ABV-press, 2022-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background. The role of neoadjuvant chemotherapy (NACT) in luminal HER2-negative breast cancer (BC) remains highly controversial due to the lack of reliable predictors of drug therapy efficacy.Objective: to evaluate the effectiveness of NACT in patients with aggressive luminal HER2-negative BC and t...